# DOD Glioblastoma, Resource Development Award

Source: https://welltoldgrants.com/grants/ht942524gbmrprda-dod-glioblastoma-resource-development-award/  
Official notice: https://www.grants.gov/search-results-detail/356429

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 5 awards worth $4.0 million in total. Applications closed on November 20, 2024.

| Field | Value |
|---|---|
| Opportunity number | HT942524GBMRPRDA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | November 20, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 5 |
| Total funding | $4.0 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The GBMRP recognizes the critical need for improved resources to advance the field of glioblastoma research and improve outcomes for individuals with glioblastoma. The FY24 GBMRP Resource Development Award supports product-driven effort focused on the advancement of preclinical model systems (in vitro and in vivo) that need further development, characterization, validation, or standardization. Studies may include, but are not limited to, the development or characterization of animal models, preclinical autologous human immune models, organoids, or patient-derived xenografts (PDXs). Proposals should include experiments that demonstrate the research tool or model improves preclinical biological relevance. Models recapitulating glioblastoma pathobiology, particularly as it relates to tumor recurrence, late-stage disease, tumor microenvironment and/or immunity component are strongly encouraged. Projects that focus primarily on investigating the pathophysiology of glioblastoma, without consideration of disease model development or characterization, are not within the scope of this funding opportunity. Key Aspects of the Resource Development Award Preliminary data is required. Applicants must demonstrate proof-of-concept data in an existing preclinical model system that the research team is looking to further develop, characterize, validate, or standardize. A Resource Distribution Plan is required. The Resource Distribution Plan should describe the means by which the fully developed resource will be made available to the scientific and/or clinical community at reasonable or appropriate administrative costs.

## Questions people ask

### Is HT942524GBMRPRDA still open?

No. It closed on November 20, 2024. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DOD Glioblastoma, Resource Development Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DOD Glioblastoma, Resource Development Award?

Closed November 20, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $4.0 million in total across about 5 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.